Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Frequency Therapeutics stock
Learn how to easily invest in Frequency Therapeutics stock.
Frequency Therapeutics Inc is a biotechnology business based in the US. Frequency Therapeutics shares (FREQ) are listed on the NASDAQ and all prices are listed in US Dollars. Frequency Therapeutics employs 72 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Frequency Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FREQ – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Frequency Therapeutics stock price (NASDAQ: FREQ)Use our graph to track the performance of FREQ stocks over time.
Frequency Therapeutics shares at a glance
|Latest market close||$1.90|
|52-week range||$1.00 - $7.88|
|50-day moving average||$2.07|
|200-day moving average||$2.66|
|Wall St. target price||$8.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.54|
Buy Frequency Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Frequency Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Frequency Therapeutics price performance over time
|1 week (2022-09-22)||5.56%|
|1 month (2022-08-29)||-10.38%|
|3 months (2022-06-29)||24.18%|
|6 months (2022-03-25)||N/A|
|1 year (2021-09-29)||-72.90%|
|2 years (2020-09-29)||-90.38%|
|3 years (2019-09-25)||N/A|
|5 years (2017-09-25)||N/A|
Frequency Therapeutics financials
|Gross profit TTM||$14.1 million|
|Return on assets TTM||-30.71%|
|Return on equity TTM||-69.74%|
|Market capitalisation||$66.6 million|
TTM: trailing 12 months
Frequency Therapeutics share dividends
We're not expecting Frequency Therapeutics to pay a dividend over the next 12 months.
Frequency Therapeutics share price volatility
Over the last 12 months, Frequency Therapeutics's shares have ranged in value from as little as $1 up to $7.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Frequency Therapeutics's is 0.7351. This would suggest that Frequency Therapeutics's shares are less volatile than average (for this exchange).
Frequency Therapeutics overview
Frequency Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited.
Frequency Therapeutics in the news
Frequency Therapeutics to Participate in September Investor and Medical Conferences
Frequently asked questionsWhat percentage of Frequency Therapeutics is owned by insiders or institutions?
Currently 7.87% of Frequency Therapeutics shares are held by insiders and 24.977% by institutions. How many people work for Frequency Therapeutics?
Latest data suggests 72 work at Frequency Therapeutics. When does the fiscal year end for Frequency Therapeutics?
Frequency Therapeutics's fiscal year ends in December. Where is Frequency Therapeutics based?
Frequency Therapeutics's address is: 75 Hayden Avenue, Lexington, MA, United States, 02421 What is Frequency Therapeutics's ISIN number?
Frequency Therapeutics's international securities identification number is: US35803L1089 What is Frequency Therapeutics's CUSIP number?
Frequency Therapeutics's Committee on Uniform Securities Identification Procedures number is: 35803L108
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert